The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Schizophrenia: More dopamine, more D 2 receptors
Open accessAbstract
Schizophrenia is a major therapeutic challenge of modern medicine, and one of the last frontiers of brain research. The illness is defined by delusions, hallucinations, disorganized behavior, and cognitive difficulties such as memory loss. It occurs in ≈1% of the world population and usually first appears in early adulthood. Although antipsychotic medications have dramatically improved the lives of patients with schizophrenia, the causes of the illness remain unknown. Of the many contemporary theories of schizophrenia, the most enduring has been the dopamine hypothesis. As originally put by Van Rossum in 1967 (ref. 1, p. 321), “When the hypothesis of dopamine blockade by neuroleptic agents can be further substantiated, it may have fargoing consequences for the pathophysiology of schizophrenia. Overstimulation of dopamine receptors could be part of the aetiology … [emphasis added].” Indeed, this speculative sentence by Van Rossum foreshadows the title of the important work by Abi-Dargham et al . (2) in this issue of PNAS: “Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.” The discovery of the antipsychotic/dopamine receptor (3, 4), now commonly known as the dopamine D2 receptor, led to repeated confirmation that it is the primary site of action for all antipsychotics (3–5), including clozapine and quetiapine (6). All these drugs have different potencies at the receptor. The potency depends on the drug's dissociation constant at D2, which, in turn, relates to the rate of release of the drug from the D2 receptor. For example, the dopamine D2 receptor releases clozapine and quetiapine more rapidly than it does any of the other antipsychotic drugs (7, 8). Given the tight correlation between the clinical potency and the D2-blocking action of the antipsychotic medications, dopamine overactivity could be the common denominator in the …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, on a neurophysiological level, a prediction error of this nature could cause an increase in the phasic activity of midbrain dopaminergic neurons, given the role that these particular neurons are believed to play in signaling salience in general and prediction errors in particular.[62][63][64][65]”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [64]
In the citing paper
“This scenario may be more relevant to the prediction errors we hypothesize to occur in schizophrenia patients, given that it is not clear that these particular predictions (eg, regarding the sensory consequences of self-generated actions) necessarily relate to reward conditioning.”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [64]
In the citing paper
“dopaminergic neurons have also been found to ''increase'' their firing rates in response to unpredictable and salient stimuli that are not conditioned to reward.63,64”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Self-citationLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Kapur, S., Zipursky, R. B., & Remington, G. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 711
Self-citationBrain receptors for antipsychotic drugs and dopamine: direct binding assays.
Seeman, P. M., Chau-Wong, M., Tedesco, J., & Wong, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4376 · Cited by 702
Self-citation(1962) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 594
D2 Dopamine Receptors in Neuroleptic-Naive Schizophrenic Patients
Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 529
Location of a Major Susceptibility Locus for Familial Schizophrenia on Chromosome 1q21-q22
Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W. C., Honer, W. G., & Bassett, A. S. (2000) · Science · doi:10.1126/science.288.5466.678 · Cited by 516
Burt, D. R., Creese, I., & Snyder, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10800-6 · Cited by 482
Flagged first, then by citations
Research works printed but not linked: 7
- J Van Rossum Neuropsychopharmacology, Proceedings Fifth Collegium Internationale Neuropsychopharmacologicum, eds H Brill, J Cole, P Deniker, H Hippius, P B Bradley (Excerpta Medica, Amsterdam), pp. 321–329 (1967).
- D R Burt, I Creese, S H Snyder Mol Pharmacol 12, 800–812 (1976).
- Kapur S. Zipursky R. Jones C. Shammi C. S. Remington G. & Seeman P. (2000) Arch. Gen. Psychiatry in press.
- S Kapur, P Seeman J Psychiatr Neurosci 25, 161–166 (2000).
- P Seeman Neuropsychopharmacology 7, 261–284 (1992).
- A C Barton, L E Black, D R Sibley Mol Pharmacol 39, 650–658 (1991).
- M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami, H Hamaguchi Mol Pharmacol 49, 560–566 (1996).
Cited by
Sorted by citations
Items 201–279 of 279
Modulation of dopamine D2 receptors as a basis of antipsychotic effect
(2003) · CRC Press eBooks · doi:10.3109/9780203427347-4 · Cited by 5
Murray, T. F. (2019) · doi:10.1002/9781119226253.ch4 · Cited by 5
Everett, A., & Elsheikha, H. M. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578588 · Cited by 4
Choudhary, A., Ekambaram, M., Ramalingam, K., Kathiravan, S., Madhan, L., Sivasankari, V., & Balasubramanian, A. (2023) · International Journal of experimental research and review · doi:10.52756/ijerr.2023.v32.004 · Cited by 4
Bharadwaj, R., Nath, P., Phukan, J. K., Deb, K., Gogoi, V., Bhattacharyya, D. K., & Barah, P. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.05.050 · Cited by 4
Understanding the Social Etiology of Psychosis
McKenzie, K. J., & Shah, J. L. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139424745.016 · Cited by 4
Modeling the Positive Symptoms of Schizophrenia
Alkam, T., & Nabeshima, T. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00004-3 · Cited by 4
Avramescu, R. G., & Flores, C. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.230015 · Cited by 4
Grecucci, A., Orsini, C., Lapomarda, G., Sorella, S., & Messina, I. (2023) · Neuroimage Reports · doi:10.1016/j.ynirp.2023.100173 · Cited by 2
Wimberley, C., Fischer, K., Reilhac, A., Pichler, B. J., & Grégoire, M. C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.050 · Cited by 3
Dopamine Receptor Imaging in Schizophrenia
Hirvonen, J., & Hietala, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00013-0 · Cited by 3
Consequences of Antipsychotic Medications on Mental Health
Bukhari, S. N. A. (2022) · Current Drug Safety · doi:10.2174/1574886317666220216101106 · Cited by 3
Parkhomenko, A. A., Zastrozhin, M. S., Skryabin, V., Ivanchenko, V. A., Pozdniakov, S. A., Noskov, V. V., Zaytsev, I. A., Денисенко, Н. П., Akmalova, K. A., Bryun, E. A., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4444 · Cited by 3
Unraveling the Role of Dopamine Receptors In Vivo: Lessons from Knockout Mice
Tirotta, E., Mei, C. D., Iitaka, C., Ramos, M., Holmes, D., & Borrelli, E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_12 · Cited by 3
Biogenic amine transmitters: Acetylcholine, norepinephrine, and dopamine
Murray, T. F. (2019) · Cited by 3
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19Preprint
Le, B. L., Andreoletti, G., Oskotsky, T., Vallejo-Gracia, A., Rosales, R., Yu, K., Kosti, I., Leon, K. E., Bunis, D. G., Li, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-333578/v1 · Cited by 3
A corticostriatal learning mechanism linking excess striatal dopamine and auditory hallucinationsPreprint
Lakshminarasimhan, K. J., Buck, J., Kellendonk, C., & Horga, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.18.643990 · Cited by 3
Bridging migraine and psychosis: a neuropsychiatric review of shared dopaminergic mechanisms
Rajan, R. J. A., & Roshini Esther, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1577146 · Cited by 2
Grecucci, A., Scarano, A., Bruno, F., Salvato, G., Yi, X., & Stella, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119708 · Cited by 2
Su, P., Wong, A. H. C., & Liu, F. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622499-00202 · Cited by 2
Clozapine Response for Vocal Tics in Schizophrenic Patients: A Case Report With Literature Review
Begum, G., Nkemjika, S., Olayinka, O. O., Olupona, T., & Jolayemi, A. (2021) · Cureus · doi:10.7759/cureus.14111 · Cited by 2
Skryabin, V. Y., Застрожин, М. С., Parkhomenko, A. A., Pankratenko, E. P., Pozdnyakov, S. A., Денисенко, Н. П., Akmalova, K. A., Bryun, E. A., & Sychev, D. A. (2023) · Hospital Pharmacy · doi:10.1177/00185787231155842 · Cited by 2
Tan, E., Chong, S., Teo, Y., & Mythily, S. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20025 · Cited by 2
THE SUBCORTICAL CONFINEMENT HYPOTHESIS: A NEUROLOGICAL MODEL FOR SCHIZOTYPAL HALLUCINATIONS.
Golembiewski, J. A. (2013) · Cureus · doi:10.7759/cureus.118 · Cited by 2
Desbonnet, L. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00016-x · Cited by 3
Nestoros, J. N., & Vallianatou, N. G. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.923695 · Cited by 2
Skryabin, V. Y., Застрожин, М. С., Parkhomenko, A. A., Lauschke, V. M., Vv, S., Петухов, А. Е., Pankratenko, E. P., Pozdnyakov, S., Koporov, S., Денисенко, Н. П., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666221228112643 · Cited by 2
Gupta, V., & Verma, L. (2024) · Eurasian Journal of Analytical Chemistry · doi:10.53555/ejac.v19i1.1029 · Cited by 1
Underexplored Connections Between Diabetes, Hypomanic States and Insecure Attachment
Bogdanova, D., Maes, M. H. J., & Stoyanov, D. (2025) · Psychology Research and Behavior Management · doi:10.2147/prbm.s524823 · Cited by 1
Buoey, M. (2016) · Journal of psychiatry · doi:10.4172/2378-5756.1000395 · Cited by 1
Su, P., Lee, F. H. F., & Liu, F. (2018) · Neuromethods · doi:10.1007/978-1-4939-8576-0_11 · Cited by 1
Saleki, K., & Rezaei, N. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_21 · Cited by 1
Chen, X., Li, F. Y., Zhao, X., Chen, L., Xue, J., Yao, Z., Gan, Z., Lian, X., Liu, Z., Tong, L., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003289 · Cited by 1
Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms
Кирничная, К. А., Sosin, D. N., Ivanov, M. V., Mikhaylov, V. A., Ivashchenko, D. V., Ершов, Е. Е., Taraskina, A. E., Nasyrova, R. F., & Krupitsky, E. M. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201511541113-125 · Cited by 1
Computational Pharmacophore Modelling of 5-HT2a and D2 Receptor Inhibitors of Schizophrenia
Zainab, R., Elahi, S., Kaleem, A., Hoessli, D. C., Iqtedar, M., Abdullah, R., Saleem, F., Khan, S. R., Ijaz, A., Naz, S., et al. (2018) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/2018.50.6.2331.2342 · Cited by 1
Neurodynamical modeling of arbitrary visuomotor tasks
Loh, M. (2008) · Repositori digital de la UPF (Universitat Pompeu Fabra) · Cited by 1
Hänninen, K. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Regulation of Dopamine Receptor Trafficking and Responsiveness
Perreault, M. L., Verma, V., O’Dowd, B. F., & George, S. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_8 · Cited by 1
Biogenic Amine Transmitters: Acetylcholine, Norepinephrine, and Dopamine
Crowell‐Davis, S. L., & Murray, T. F. (2005) · doi:10.1002/9780470344521.ch7 · Cited by 1
Ji, J. L., Lencz, T., Gallego, J. A., Neufeld, N. H., Voineskos, A. N., Malhotra, A. K., & Anticevic, A. (2023) · medRxiv · doi:10.1101/2023.03.10.23286854 · Cited by 1
The Relationship Between Nutrition and Neurocognitive Function in Schizophrenia
Fleming, M. P., & Martin, C. R. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_121
Lipogenic effects of antipsychotic drugs in cultured cells and in rat
Fernø, J. (2007) · NORA - Norwegian Open Research Archives
Onset, course and comorbidity of bipolar symptoms in population and treatment settings
Rossum, I. W.-V. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100114ir
Animal Models and Procedures for CNS Disorders
Cutler, N. R., Sramek, J. J., Murphy, M. F., Riordan, H., Bieck, P. R., & Carta, A. (2010) · Wiley eBooks · doi:10.1002/9781444318579.ch2
McCreary, A. C., Feenstra, R., & Jones, C. A. (2012) · doi:10.1002/9781118309421.ch9
Allosteric Modulators: Potential Treatment for Schizophrenia
Daya, R. P. (2012) · The Meducator · doi:10.15173/m.v1i20.786
Delfin, C. (2014) · Högskolan Kristianstad Publikationer
Structural brain changes in adolescents at risk for psychosis
Weusten, J. (2010) · Utrecht University Repository (Utrecht University)
Studying prepulse inhibition in a stressed system
Douma, T. N. (2013) · Utrecht University Repository (Utrecht University)
Uso della PET e della SPECT in Psichiatria
Peri, L. M. D., & Vita, A. (2010) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2010.10.005
Применение системного подхода при изучении природно-техногенных геосистем
Pochechun, V. A., Леонидович, М. Ю., & Александрович, Б. Д. (2014) · Tambov University Reports Series Natural and Technical Sciences
Ivanova, B. B., & Spiteller, M. (2012) · Natural Product Research · doi:10.1080/14786419.2012.704375
RetractedLes systèmes de neurotransmission centraux et leur implication dans les psychoses
Martres, M. (2008) · Therapies · doi:10.2515/therapie:2008030
Pertegaz, I. B. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Tomografía por emisión de fotón único
Domínguez‐Gadea, L. (2008) · Elsevier eBooks · doi:10.1016/b978-84-458-1776-6.50006-x
Gabriele, J. P., Groleau, S. E., Daya, R. P., Pristupa, Z. B., & Mishra, R. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-3027-4_12
Neurobiological Features of Dopamine D2 Receptors
Usiello, A., Iaccarino, C., & Borrelli, E. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4757-3538-3_41
The Neurobiological Determinants of Creativity
Scurfield, A. (2015) · Sound Ideas (University of Puget Sound)
Francesc Ramis Darder i els profetes
Ferrer, J. (2002) · Butlletí de l'Associació Bíblica de Catalunya
Arranz, M. J., Mancama, D. T., & Kerwin, R. W. (2016) · doi:10.3109/9781420016697-18
Galdino, D. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Neuroinflammation and psychosis; antipsychotic medication.
Bloomfield, P. S. (2015) · Spiral (Imperial College London) · doi:10.25560/39588
Negruțiu, M. L., Ogodescu, A. S., Petrescu, E.-L., Sinescu, C. G., Topala, F. I., Pop, D. M., Romînu, M., Drăgănescu, G. E., & Podoleanu, A. G. (2011) · Kent Academic Repository (University of Kent)
Joel Paris, M. D. (2010) · Wiley eBooks · doi:10.1002/9780470666630.refs
Exploración de las alteraciones de la conectividad funcional en esquizofrenia
Lorenzana, A. R. (2021) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/52880
Risch, S. C. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.01062-9
The Genetics of Antipsychotic Response
Arranz, M. J., Mancama, D. T., & Kerwin, R. W. (2006) · CRC Press eBooks · doi:10.3109/9781420016697-15
Derval, D., & Bremer, J. (2012) · SpringerBriefs in business · doi:10.1007/978-3-642-25713-1_5
Chronischer Streß auf der Ebene der Molekularbiologie und Neurobiochemie
Mosetter, K. (2008) · VS Verlag für Sozialwissenschaften eBooks · doi:10.1007/978-3-531-91141-0_3
Cariprazine: A Complete Solution for Full-Spectrum Bipolar I Disorder?
Bhattacharyya, R. (2022) · D Y Patil Journal of Health Sciences · doi:10.4103/dypj.dypj_61_21
Atypical Antipsychotics Use and Neuroleptic Malignant Syndrome: A Review With a Clinical Perspective
Kim, K. (2024) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2024.27.2.29
Grecucci, A., Scarano, A., Bruno, F., Salvato, G., Yi, X., & Stella, M. (2025) · Research Square · doi:10.21203/rs.3.rs-6113218/v1
Virtual brain twins guide personalized treatment decision in schizophreniaPreprint
Preti, G., Wang, H. E., Ziaeemehr, A., Woodman, M., Prodan, P., Triebkorn, P., Chang, X., Sacha, M., Fey, M., Breyton, M., et al. (2026) · medRxiv · doi:10.64898/2026.05.06.26352533
Analysing dopamine receptor interacting proteins using the biomedical model Dictyostelium discoideum
Pakes, N. K. (2012) · Royal Holloway Digital Repository (Royal Holloway University of London)
Metadata
- Authors
- Seeman, P., & Kapur, S.
- Affiliations
- University of Toronto (CA)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-07-05
- Volume
- 97
- Issue
- 14
- Pages
- 7673-7675
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC33999
- OpenAlex
- W2022725791
- Cited by
- 279
- References
- 22
- Citations by year
- 2026: 1 · 2025: 14 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 15 · 2020: 5 · 2019: 12 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 15 · 2014: 19 · 2013: 14 · 2012: 13
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, dopamine hypothesis, dopamine D2 receptor, receptor occupancy, antipsychotic drugs, clozapine, quetiapine, receptor dissociation constant, schizophrenia pathophysiology
- MeSH terms
- Benzamides, Dopamine, Models, Biological, Psychotic Disorders, Pyrrolidines, Schizophrenia, Receptors, Dopamine D2, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
